Applied Materials Inc (AMAT.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS

The bull case activates when the 2028 digestion year never arrives. Sustained HBM4 and sub-2nm conversions keep DRAM and foundry spending compounding above 20%, clean-room constraints ease, and AMAT's packaging content per wafer rises with hybrid bonding. Completed capacity investment then releases free cash, restoring buybacks at scale just as estimates migrate upward. Earnings near $35 by fiscal 2031 meet a low-thirties multiple, and the shares roughly double from here rather than compounding modestly.

The bear case activates when AI capex conviction cracks while China share loss accelerates simultaneously. A hyperscaler spending pause cuts WFE 15-20%, orders roll over in 2028, and the fixed-cost absorption that produced thirteen quarters of margin expansion reverses. Chinese domestic toolmakers meanwhile capture the mature-node installed base, permanently shrinking the service annuity. EPS compresses toward $12 against an 18x cyclical-trough multiple, and the stock revisits the low $200s before stabilizing.

The settled belief is that AMAT is the cheap picks-and-shovels way to own AI: thirty-nine analysts average a $640.89 target, MarketBeat shows $658, UBS raised to $695 — all roughly 45% above spot [26][27][23]. The anchor is the $739 high, not the cash flows. China's slide from 35% to 28% of revenue is treated as timing noise rather than structural share loss.

The crowd modestly underestimates these shares, though far less than the $640 average target implies [26]. The decisive overlooked evidence is definitional: trailing 38.4x rests on tax-inflated GAAP EPS, while the $4.02 fourth-quarter guide annualizes near $16, putting spot closer to 28x forward earnings that are still accelerating [8]. The blind spot cuts both ways — the same crowd under-weights 61% free-cash conversion, which throttles the buyback that historically turned cycle earnings into per-share value.

The November 2026 fourth-quarter report is the trigger: delivery against the $10.25bn revenue and $4.02 EPS guide, plus the first fiscal-2027 framing, forces estimate migration [9]. The first observable sign of repricing is forward P/E re-anchoring below 30x as consensus EPS rises faster than the share price.